Strategic Acquisition Since becoming part of Altasciences in 2020, WCCT Global has integrated into a broader platform with a focus on early phase drug development, presenting opportunities for collaboration in innovative and specialized clinical trial services.
Sustainability Commitment Partnerships such as EcoVadis demonstrate Altasciences' focus on environmental, social, and governance initiatives, indicating a market trend where clients prioritize sustainable practices and may seek environmentally responsible research services.
Technology Integration The company's use of advanced tech stacks including 3D tissue technology through VoxCell BioInnovation suggests a capability to support and grow with clients seeking cutting-edge preclinical testing and innovative research solutions.
Awards & Recognition Recent accolades like the CDMO Leadership Award and CRO Capabilities Award highlight the company's strong industry reputation, making it a compelling partner for clients aiming for high-quality drug development and testing services.
Growth & Expansion Expanding facilities in Montreal and hiring new leadership indicate ongoing growth and capacity enhancement, providing sales opportunities with clients seeking reliable and scalable research and development collaborations.